These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32058056)

  • 1. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe.
    Caris JA; Benzi JRL; de Souza FFL; de Oliveira RDR; Donadi EA; Lanchote VL
    Eur J Pharm Sci; 2020 Apr; 146():105264. PubMed ID: 32058056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers.
    Kirchheiner J; Kudlicz D; Meisel C; Bauer S; Meineke I; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Aug; 74(2):186-94. PubMed ID: 12891229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective analysis of fluvastatin in human plasma for pharmacokinetic studies.
    Lanchote VL; Rocha A; de Albuquerque FU; Coelho EB; Bonato PS
    J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):81-8. PubMed ID: 11817313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiospecific Pharmacogenomics of Fluvastatin.
    Hirvensalo P; Tornio A; Neuvonen M; Kiander W; Kidron H; Paile-Hyvärinen M; Tapaninen T; Backman JT; Niemi M
    Clin Pharmacol Ther; 2019 Sep; 106(3):668-680. PubMed ID: 30989645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecific disposition of fluvastatin in streptozotocin-induced diabetic rats.
    Rocha A; Coelho EB; Lanchote VL
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1071-5. PubMed ID: 12489926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectrometry.
    Di Pietro G; Coelho EB; Geleilete TM; Marques MP; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):256-61. PubMed ID: 16480934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of Atorvastatin.
    Cestari RN; de Oliveira RDR; de Souza FFL; Pippa LF; Nardotto GHB; Rocha A; Donadi EA; Lanchote VL
    Clin Transl Sci; 2020 Nov; 13(6):1227-1235. PubMed ID: 32463566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers.
    Mori D; Kashihara Y; Yoshikado T; Kimura M; Hirota T; Matsuki S; Maeda K; Irie S; Ieiri I; Sugiyama Y; Kusuhara H
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):78-86. PubMed ID: 30528195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
    Misaka S; Abe O; Sato H; Ono T; Shikama Y; Onoue S; Yabe H; Kimura J
    Eur J Clin Pharmacol; 2018 May; 74(5):601-609. PubMed ID: 29368187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions.
    Alam K; Pahwa S; Wang X; Zhang P; Ding K; Abuznait AH; Li L; Yue W
    Mol Pharm; 2016 Mar; 13(3):839-51. PubMed ID: 26750564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis.
    Ono H; Tanaka R; Suzuki Y; Oda A; Ozaki T; Tatsuta R; Maeshima K; Ishii K; Ohno K; Shibata H; Itoh H
    Clin Pharmacol Ther; 2021 Oct; 110(4):1096-1105. PubMed ID: 34319605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin.
    Kim MJ; Nafziger AN; Kashuba AD; Kirchheiner J; Bauer S; Gaedigk A; Bertino JS
    Eur J Clin Pharmacol; 2006 Jun; 62(6):431-6. PubMed ID: 16758259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers.
    Boralli VB; Coelho EB; Sampaio SA; Marques MP; Lanchote VL
    J Clin Pharmacol; 2009 Feb; 49(2):205-11. PubMed ID: 19033449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis.
    Główka F; Karaźniewicz-Łada M; Grześkowiak E; Rogozinska D; Romanowski W
    Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):167-73. PubMed ID: 21516380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluconazole on plasma fluvastatin and pravastatin concentrations.
    Kantola T; Backman JT; Niemi M; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Jun; 56(3):225-9. PubMed ID: 10952477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinical Study Evaluating the Effects of Fluvastatin on Serum Osteoprotegerin Levels in Rheumatoid Arthritis Patients.
    Hegazy SK; El-Ghany El-Sayed Sel-M; El-Hefnawy Mel-S
    J Clin Pharmacol; 2016 Oct; 56(10):1272-6. PubMed ID: 26899523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation.
    Suzumura K; Odawara A; Yasuhara M; Tanaka K; Narita H; Suzuki T
    Biol Pharm Bull; 1999 Sep; 22(9):971-4. PubMed ID: 10513623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
    Niemi M; Pasanen MK; Neuvonen PJ
    Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.